Correlations of bcl-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Oral Oncology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1368-8375(98)00055-4PMID 10211311
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Overexpression of bcl-2 protein inhibits terminal differentiation of oral keratinocytes in vitro.

  2007cited by this paper
• p53 aberrations in oral submucous fibrosis and oral squamous cell carcinoma detected by immunocytochemistry and PCR-SSCP.

  2007cited by this paper
• Histological Typing of Cancer and Precancer of the Oral Mucosa

  1997cited by this paper
• bcl-2 protein expression correlates with recurrence and survival in early stage head and neck cancer treated by radiotherapy.

  1996cited by this paper
• bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas.

  1996cited by this paper
• p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma.

  1996cited by this paper
• bcl‐2 expression and prognosis in squamous‐cell carcinomas of the esophagus

  1996cited by this paper
• p53 overexpression in head and neck squamous cell carcinoma: review of the literature.

  1996cited by this paper
• Expression of bcl-2 and the progression of human and rodent prostatic cancers.

  1996cited by this paper
• Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity.

  1996cited by this paper
• Discordance of p53 status in matched primary tumours and metastases in head and neck squamous cell carcinoma patients.

  1996cited by this paper
• p53 Expression: Predicting Recurrence and Second Primary Tumors in Head and Neck Squamous Cell Carcinoma

  1996cited by this paper
• The possible role of bcl–2 expression in the progression of tumors of the uterine cervix

  1995cited by this paper
• bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis.

  1995cited by this paper
• p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers

  1995cited by this paper
• P53, cell cycle control and apoptosis: Implications for cancer

  1995cited by this paper
• Immunohistochemical detection of p53 protein in archival tissues from squamous cell carcinomas of the oral cavity using wet autoclave antigen retrieval

  1995cited by this paper
• Apoptosis. Its significance in cancer and cancer Therapy

  1994cited by this paper
• Immunohistochemical analysis of p53 in gynecologic tumors.

  1994cited by this paper
• Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.

  1994cited by this paper
• Association of overexpression of p53 oncoprotein with the state of cell proliferation in oral carcinoma.

  1994cited by this paper
• The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa.

  1994cited by this paper
• The regulation of p53 function: Steiner award lecture

  1994cited by this paper
• Multifactorial analysis of p53 alteration in human cancer: A review

  1994cited by this paper
• Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line.

  1993cited by this paper
• Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells.

  1993cited by this paper
• Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.

  1993cited by this paper
• Intratumoral microvessel density and L53 protein: Correlation with metastasis in head‐and‐neck squamous‐cell carcinoma

  1993cited by this paper
• Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

  1992cited by this paper
• Definitions and Explanatory Notes

  1992cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• Increased expression of mutant forms of p53 oncogene in primary lung cancer.

  1990cited by this paper
• Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

  1988cited by this paper
• Involvement of the bcl-2 gene in human follicular lymphoma.

  1985cited by this paper
• Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation.

  1984cited by this paper
• A methodologic study of histologic classification and grading of malignancy in oral squamous cell carcinoma.

  1984cited by this paper

• BCL-2 and BCL-xL in Cancer: Regulation, Function, and Therapeutic Targeting

  2026cites this paper
• Investigating regulated signaling pathways in therapeutic targeting of non-small cell lung carcinoma.

  2023cites this paper
• Immunohistochemistry examination to reveal the pathogenesis of Oral Squamous Cell Carcinoma

  2023cites this paper
• DNA Fragmentation and mRNA Expression of Bcl-2, Bcl-xL, p53, p21 and HSP70 Genes in Nondysplastic and Dysplastic Oral Lichen Planus

  2022cites this paper
• study of the expression of CD44 and Bcl-2 in oral squamous cell carcinoma and it’s correlation with histological grading

  2022cites this paper
• Cannabinoids Inhibit Cellular Respiration of Human Oral Cancer Cells

  2019cites this paper
• Differential expression of cell proliferation and apoptosis markers in squamous cell carcinoma of the tongue in young and old patients

  2018cites this paper
• Expression of E-cadherin and B-cell lymphoma 2 in oral cancer: A ratio-based planning for targeted therapy

  2017cites this paper
• Immunohistochemical expression of p53 and c-Myc at the invasive front of oral squamous cell carcinoma and its relation with clinicopathologic characteristics.

  2017cites this paper
• Clinicopathological correlation of Bcl-2 oncoprotein expression in oral precancer and cancer.

  2016cites this paper
• The influence of sleep restriction on expression of apoptosis regulatory proteins p53, Bcl-2 and Bax following rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide.

  2015cites this paper
• ORAL SQUAMOUS PAPILLOMA AND SQUAMOUS CELL CARCINOMA; DIAGNOSTIC UTILITY OF P53 IN DIFFERENTIATING

  2015cites this paper
• Immunohistochemical Study of Integrin &agr;5&bgr;1, Fibronectin, and Bcl-2 in Normal Oral Mucosa, Inflammatory Fibroepithelial Hyperplasia, Oral Epithelial Dysplasia, and Oral Squamous Cell Carcinoma

  2013cites this paper
• Immunoexpression of p53 in Oral Squamous Cell Carcinoma and Oral Dysplastic Lesions in Patients with the Habit of Reverse Smoke

  2013cites this paper
• The influence of sleep deprivation on expression of apoptosis regulatory proteins p53, bcl-2 and bax following rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide

  2013cites this paper
• Prognostic Implications of MicoRNA miR-195 Expression in Human Tongue Squamous Cell Carcinoma

  2013cites this paper
• p16 overexpression in malignant and premalignant lesions of the oral and esophageal mucosa following allogeneic hematopoietic stem cell transplantation

  2012cites this paper
• The role of canonical WNT signaling pathway in oral carcinogenesis: a comprehensive review.

  2012cites this paper
• Clinicopathological significance of carbonic anhydrase 9, glucose transporter-1, Ki-67 and p53 expression in oral squamous cell carcinoma.

  2011cites this paper
• Estudio de los reguladores del ciclo celular asociados al desarrollo de cáncer oral en una muestra de la provincia de Álava

  2011cites this paper
• Proliferation and apoptosis markers in oral submucous fibrosis

  2011cites this paper
• Bcl-2 targeted-therapy for the treatment of head and neck squamous cell carcinoma.

  2011cites this paper
• Expression of Bcl‐2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma

  2010cites this paper
• Apoptosis-inducing activity and tumor-specificity of antitumor agents against oral squamous cell carcinoma

  2010cites this paper
• Cannabinoids Inhibit Cellular Respiration of Human Oral Cancer Cells

  2010cites this paper
• Tight junction proteins and cancer-associated fibroblasts in ameloblastoma, ameloblastic carcinoma and mobile tongue cancer

  2010cites this paper
• Effect of curcumin and ferulic acid on modulation of expression pattern of p53 and bcl-2 proteins in 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis.

  2010cites this paper
• Mutation Status of p 53 Gene in Oral Squamous Cell Carcinoma

  2010cites this paper
• Cancer genes alterations and HPV infection in oral squamous cell carcinoma.

  2010cites this paper
• Expression of bcl-2 and bax in chewing tobacco-induced oral cancers and oral lesions from India

  2009cites this paper
• Mutation status of p53 gene in oral squamous cell carcinoma

  2009cites this paper
• Presence of dominant negative mutation of TP53 is a risk of early recurrence in oral cancer.

  2008cites this paper
• Oral Submucous Fibrosis: A study of prevalence, potential biomarkers of malignancy and chemopreventive agents in vitro.

  2008cites this paper
• Gene expression profile changes correlated with lymph node metastasis in oral squamous cell carcinoma

  2008cites this paper
• Analysis of the anti-apoptotic protein bcl-2 in oral squamous cell carcinoma

  2007cites this paper
• Analiza antiapoptotskog proteina bcl-2 u skvamocelularnom karcinomu usne regije Analysis of the anti-apoptotic protein bcl-2 in oral squamous cell carcinoma

  2007cites this paper
• Establishment and characterization of a tumorigenic cell line from areca quid and tobacco smoke-associated buccal carcinoma.

  2007cites this paper
• Phenotypic alterations in Rb pathway have more prognostic influence than p53 pathway proteins in oral carcinoma

  2005cites this paper
• Small interfering RNA-induced CHFR silencing sensitizes oral squamous cell cancer cells to microtubule inhibitors

  2005cites this paper
• Selective reporting biases in cancer prognostic factor studies.

  2005cites this paper
• Prognostic value of apoptosis and apoptosis‐associated proteins in salivary gland adenoid cystic carcinoma

  2004cites this paper
• Expression of vascular endothelial growth factor and prognosis of oral squamous cell carcinoma.

  2004cites this paper
• Expression of Cell Proliferation and Apoptosis Markers in Papillomas and Cancers of Conjunctiva and Eyelid

  2004cites this paper
• Estudo comparativo da imunomarcação da p53 em carcinomas epidermóides bucais de sítios anatômicos diferentes

  2004cites this paper
• Expression of bcl-2 in oral squamous cell carcinoma: an immunohistochemical study of 90 cases with clinico-pathological correlations.

  2003cites this paper
• Prognostic Role of Apoptotic, Bcl-2, c-erbB-2 and p53 Tumor Markers in Salivary Gland Malignancies

  2003cites this paper
• Cell death regulation in oral squamous cell carcinoma: methodological considerations and clinical significance.

  2003cites this paper
• Valor pronóstico del parámetro inmunohistoquímico p53 en los estadios I y II del carcinoma epidermoide de lengua móvil

  2003cites this paper
• Thymidine phosphorylase expression in oral squamous cell carcinoma.

  2002cites this paper
• Decreased expression of bcl-2 in moderate and severe oral epithelia dysplasias.

  2002cites this paper
• Emerging new therapies for chemotherapy-resistant cancer using adenoviral vectors.

  2002cites this paper
• Squamous cell carcinoma of the tongue: the prevalence and prognostic roles of p53, Bcl-2, c-erbB-2 and apoptotic rate as related to clinical and pathological characteristics in a retrospective study.

  2002cites this paper
• Clinicopathologic significance of bcl-2 expression in the surgical treatment of oral tongue carcinoma.

  2002cites this paper
• The role of MDM2 in the proliferative activity of ameloblastoma.

  2002cites this paper
• Tissue and serum borne tumor markers of oral squamous cell carcinoma: present and forthcoming therapeutic roles

  2002cites this paper
• Head and neck cancer: gene therapy approaches.Part II: genes delivered

  2002cites this paper
• P53 protein expression in oral squamous cell carcinoma. survival analysis.

  2001cites this paper
• Expression of p53 in oral squamous cell carcinoma and its association with risk habits in southern Thailand.

  2001cites this paper
• Cancer of the oral cavity.

  2001cites this paper
• The clinicopathologic significance of p53 and p21 expression in the surgical management of lingual squamous cell carcinoma.

  2001cites this paper
• Cancer of the oral cavity.

  2000cites this paper
• Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications.

  2000cites this paper
• Induction of apoptosis in oral cancer cells by an anti-bcl-2 ribozyme delivered by an adenovirus vector.

  2000cites this paper
• Bcl-2 expression in sequential biopsies of potentially malignant oral mucosal lesions assessed by immunocytochemistry.

  2000cites this paper
• Cancer of the tongue in Finland : incidence, detection, survival and prognostic factors

  2000cites this paper